| First Author | Sen Santara S | Year | 2023 |
| Journal | Nature | Volume | 616 |
| Issue | 7956 | Pages | 348-356 |
| PubMed ID | 37020026 | Mgi Jnum | J:340008 |
| Mgi Id | MGI:7525545 | Doi | 10.1038/s41586-023-05912-0 |
| Citation | Sen Santara S, et al. (2023) The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells. Nature 616(7956):348-356 |
| abstractText | Natural killer (NK) cell kill infected, transformed and stressed cells when an activating NK cell receptor is triggered(1). Most NK cells and some innate lymphoid cells express the activating receptor NKp46, encoded by NCR1, the most evolutionarily ancient NK cell receptor(2,3). Blockage of NKp46 inhibits NK killing of many cancer targets(4). Although a few infectious NKp46 ligands have been identified, the endogenous NKp46 cell surface ligand is unknown. Here we show that NKp46 recognizes externalized calreticulin (ecto-CRT), which translocates from the endoplasmic reticulum (ER) to the cell membrane during ER stress. ER stress and ecto-CRT are hallmarks of chemotherapy-induced immunogenic cell death(5,6), flavivirus infection and senescence. NKp46 recognition of the P domain of ecto-CRT triggers NK cell signalling and NKp46 caps with ecto-CRT in NK immune synapses. NKp46-mediated killing is inhibited by knockout or knockdown of CALR, the gene encoding CRT, or CRT antibodies, and is enhanced by ectopic expression of glycosylphosphatidylinositol-anchored CRT. NCR1)-deficient human (and Nrc1-deficient mouse) NK cells are impaired in the killing of ZIKV-infected, ER-stressed and senescent cells and ecto-CRT-expressing cancer cells. Importantly, NKp46 recognition of ecto-CRT controls mouse B16 melanoma and RAS-driven lung cancers and enhances tumour-infiltrating NK cell degranulation and cytokine secretion. Thus, NKp46 recognition of ecto-CRT as a danger-associated molecular pattern eliminates ER-stressed cells. |
